Enhancing Intermolecular Benzoyl-Transfer Reactivity in Crystals
FULL PAPER
(0.040 g) at 50 psi. After 6 h, the reaction mixture was filtered over a
short bed of Celite, which was subsequently washed with ethyl acetate
(10 mL). Evaporation of the solvents from the filtrate and washings
under reduced pressure followed by column chromatography (eluent:
ethyl acetate/light petroleum 1:2) afforded 1 as a white solid (0.380 g,
95%). The dibenzoate 1 could be crystallized for single-crystal X-ray dif-
fraction studies by slow diffusion of light petroleum into a chloroform so-
m.p. 175–1778C); [a]D30 =+6.4 (c=1 in MeOH) (lit.:[29a] [a]D22 =+6 (c=1
in MeOH)).
d-2,6-Di-O-benzoyl-myo-inositol-1,3,5-orthoformate (ent-1): A solution
of ent-13 (0.3 g, 0.61 mmol) was hydrogenolyzed in methanol (2 mL) and
ethyl acetate (3 mL) in the presence of 20% Pd(OH)2/C (0.025 g) as in
the preparation of 1 to give ent-1 as a white solid (0.234 g, 96%). The di-
benzoate ent-1 could be crystallized for single-crystal X-ray diffraction
studies by slow diffusion of light petroleum into a chloroform solution of
ent-1 in a closed container at RT. Rf =0.28; m.p. 163–1658C; [a]2D7 =À65.1
(c=1 in CHCl3); 1H NMR (CDCl3, 200 MHz, TMS): d=8.10–8.20 (m,
2H; Ar H), 7.99–8.09 (m, 2H; Ar H), 7.54–7.66 (m, 2H; Ar H), 7.40–
7.52 (m, 4H; Ar H), 5.84 (dt, 1H, J=4.0, 1.8 Hz; Ins H), 5.63–5.70 (m,
2H; Ins H, HCO3), 4.69–4.81 (m, 1H; Ins H), 4.56–4.67 (m, 2H; Ins H),
4.45–4.54 (m, 1H; Ins H), 2.65 ppm (d, 1H, J=5.4 Hz; OH); 13C NMR
(CDCl3, 50.3 MHz, TMS): d=166.3 (C=O), 165.3 (C=O), 133.7 (Carom),
133.5 (Carom), 129.9 (Carom), 129.8 (Carom), 129.3 (Carom), 128.8 (Carom), 128.6
(Carom), 128.5 (Carom), 102.9 (HCO3), 71.7 (Ins C), 69.6 (Ins C), 68.5 (Ins
C), 68.4 (Ins C), 67.3 (Ins C), 63.8 ppm (Ins C); IR (CHCl3): n˜ =3412,
1722, 1703 cmÀ1; elemental analysis calcd (%) for C21H18O8: C 63.31, H
4.55; found: C 63.01, H 4.41.
lution of 1 in a closed container at RT. Rf =0.27; m.p. 162–1648C; [a]D22
=
+66.0 (c=1 in CHCl3); 1H NMR (CDCl3, 200 MHz, TMS): d=8.02–8.20
(m, 4H; Ar H), 7.55- 7.70 (m, 2H; Ar H), 7.39–7.54 (m, 4H; Ar H), 5.83
(dt, 1H, J=3.7, 1.6 Hz; Ins H), 5.62–5.75 (m, 2H; Ins H, HCO3), 4.70–
4.82 (m, 1H; Ins H), 4.56–4.67 (m, 2H; Ins H), 4.45–4.55 (m, 1H; Ins H),
2.69 ppm (d, 1H, J=5.8 Hz; OH); 13C NMR (CDCl3, 50.3 MHz, TMS):
d=166.3 (C=O), 165.3 (C=O), 133.6 (Carom), 129.9 (Carom), 129.8 (Carom),
129.3 (Carom), 128.8 (Carom), 128.6 (Carom), 128.5 (Carom), 102.9 (HCO3),
71.7 (Ins C), 69.6 (Ins C), 68.5 (Ins C), 68.4 (Ins C), 67.2 (Ins C),
63.8 ppm (Ins C); IR (CHCl3): n˜ =3540–3240, 1701, 1728 cmÀ1; elemental
analysis calcd (%) for C21H18O8: C 63.31, H 4.55; found: C 63.21, H 4.29.
d-2,6-Di-O-tosyl-4-O-benzyl-myo-inositol-1,3,5-orthoformate (ent-11): d-
2,6-Di-O-tosyl-myo-inositol-1,3,5-orthoformate
(ent-10,
0.701 g,
Crystallization of rac-2,4-di-O-benzoyl-myo-inositol-1,3,5-orthoacetate
(rac-3) in the presence of d-2,6-di-O-benzoyl-myo-inositol-1,3,5-orthofor-
mate (ent-1): The orthoacetate rac-3 (0.052 g, 0.13 mmol) and the ortho-
formate ent-1 (0.005 g, 0.01 mmol) were dissolved in chloroform (3 mL).
Light petroleum was diffused into this solution in a closed container over
4–5 days at RT. Clusters of sharp needles (0.044 g) were obtained. The
sharp needles were separated and collected (0.037 g). Use of a larger
amount of ent-1 (0.010 g or 0.050 g) for the crystallization experiment (as
above) did not make any difference in the yield of form II crystals. How-
ever, the use of a lesser amount of ent-1 (0.002 g) for the crystallization
experiment (as above) resulted in concomitant formation of both form I
and II crystals of rac-3. Form I crystals appeared faster than the form II
crystals. Crystallization of rac-3 in the absence of ent-1 in chloroform re-
sulted in form I crystals (2–3 days) alone. Similar results were obtained
on crystallization of the racemic orthoacetate rac-3 in the presence of 1.
Note: The 1H NMR spectrum of the clusters of from II crystals showed
that they contained rac-3 and ent-1 in the ratio 11:1. The ratio of the two
dibenzoates in manually separated needles (from clusters) was 20:1. The
variation in the relative amount of the two dibenzoates present in form II
crystals suggested that the form II crystals are a polymorphic modifica-
tion of the racemic orthoacetate (rac-3) contaminated with the enatio-
meric orthoformate rather than co-crystals of the two dibenzoates. This
was confirmed by single-crystal X-ray diffraction data of form II crystals
and the thermal transformation of form II crystals to form I crystals.
Washing of the crystals of rac-3 to free them from the adhering ent-1 is
not practical because both the dibenzoates have a similar solubility in or-
ganic solvents.
1.41 mmol) was benzylated with benzyl bromide (0.25 mL, 2.1 mmol) in
dry DMF (8 mL) and sodium hydride (0.068 g, 1.70 mmol) as in the prep-
aration of 11 to give ent-11 as a white solid (0.778 g, 94%). Rf =0.29;
m.p. 75–788C; [a]2D5 =+8.8 (c=1 in chloroform); 1H NMR (CDCl3,
200 MHz, TMS): d=7.68–7.83 (m, 4H; Ar H), 7.21–7.40 (m, 9H; Ar H),
5.43 (d, 1H, J=1.3 Hz; HCO3), 5.08 (dt, 1H, J=3.9, 1.64 Hz; Ins H),
4.89–4.96 (m, 1H; Ins H), 4.42–4.65 (q, 2H, J=11.6 Hz; CH2), 4.35–4.41
(m, 1H; Ins H), 4.24 (dt, 1H, J=4.1, 1.65 Hz; Ins H), 4.12–4.20 (m, 1H;
Ins H), 4.01–4.10 (m, 1H; Ins H), 2.47 (s, 3H; CH3), 2.43 ppm (s, 3H;
CH3); 13C NMR (CDCl3, 50.3 MHz, TMS): d=145.6 (Carom), 145.3 (Carom),
136.7 (Carom), 132.9 (Carom), 132.3 (Carom), 130.0 (Carom), 129.9 (Carom), 128.4
(Carom), 127.9 (Carom), 127.8 (Carom), 127.4 (Carom), 126.8 (Carom), 102.5
(HCO3), 72.3 (Ins C), 72.1 (Ins C), 71.3 (CH2), 69.9 (Ins C), 69.6 (Ins C),
68.7 (Ins C), 67.1 (Ins C), 21.6 (CH3), 21.5 ppm (CH3); elemental analysis
calcd (%) for C28H28O10S2: C 57.13, H 4.79, S 10.89; found: C 57.4, H
4.53, S 11.03.
d-4-O-Benzyl-myo-inositol-1,3,5-orthoformate (ent-12): Methanolysis of
ent-11 (0.589 g, 1.0 mmol) with sodium methoxide (0.541 g, 10.02 mmol)
in dry methanol (8 mL) as in the preparation of 12 gave ent-12 as a gum
(0.275 g, 98%). Rf =0.28; [a]2D7 =+15.3 (c=1 in ethanol); 1H NMR
(CDCl3, 200 MHz, TMS): d=7.23–7.50 (m, 5H; Ar H), 5.44 (d, 1H, J=
1.3 Hz; HCO3), 4.67 (q, 2H, J=11.6 Hz; CH2), 4.38–4.55 (m, 2H; Ins H),
4.18–4.35 (m, 3H; Ins H), 4.09 (s, 1H; Ins H), 3.75 (d, 1H, J=10.2 Hz;
OH), 3.23 ppm (s, 1H; OH); 13C NMR (CDCl3, 75.48 MHz, TMS): d=
135.8 (Carom), 128.9 (Carom), 128.8 (Carom), 128.0 (Carom), 102.7 (HCO3),
74.7 (Ins C), 74.2 (Ins C), 73.0 (CH2), 72.2 (Ins C), 67.8 (Ins C), 67.3 (Ins
C), 60.6 ppm (Ins C); IR (neat): n˜ =3200–3550 cmÀ1; elemental analysis
calcd (%) for C14H16O6: C 59.99, H 5.75; found: C 60.11, H 5.70.
Thermal analysis: The thermal behaviour of dimorphs of rac-3 was inves-
tigated by measuring the enthalpy change on a Mettller differential scan-
ning calorimeter instrument. About 3–5 mg of crystals were placed on an
aluminium pan (5 mm diameter) and were analysed from room tempera-
ture to 2008C by using an empty pan as the reference. The heating rate
was 108CminÀ1 and nitrogen gas was used for purging. DSC analysis
(Figure 3) of form II crystals of rac-3 indicated a phase change around
145–1508C. Analysis of the crystals by X-ray diffraction revealed that
this polymorph underwent crystal-to-crystal transformation on heating at
1458C to give form I crystals.
d-2,6-Di-O-benzoyl-4-O-benzyl-myo-inositol-1,3,5-orthoformate (ent-13):
Compound ent-12 (0.25 g, 0.89 mmol) was benzoylated with benzoyl chlo-
ride (0.75 g, 5.33 mmol), dry pyridine (4 mL) and DMAP (0.01 g) as in
the preparation of 13 to give ent-13 as a white solid (0.418 g, 96%). Rf =
0.35; m.p. 140–1428C; [a]D27 =À25.02 (c=1 in CHCl3); 1H NMR (CDCl3,
200 MHz, TMS): d=8.13–8.21 (m, 2H; Ar H), 7.87–7.97 (m, 2H; Ar H),
7.43- 7.68 (m, 4H; Ar H), 7.20–7.33 (m, 7H; Ar H), 5.80 (dt, J=4.0,
1.8 Hz 1H; Ins H), 5.64–5.70 (m, 2H; Ins H, HCO3), 4.69–4.76 (m, 1H;
Ins H), 4.52–4.68 (m, 4H; Ins H), 4.48 ppm (dt, 1H, J=3.8, 1.6; Ins H);
13C NMR (CDCl3, 50.3 MHz, TMS): d=166.1 (C=O), 165.3 (C=O), 136.7
(Carom), 133.4 (Carom), 133.3 (Carom), 129.9 (Carom), 129.5 (Carom), 128.9
(Carom), 128.4 (Carom), 128.3 (Carom), 128.0 (Carom), 127.9 (Carom), 103.2
(HCO3), 73.4 (Ins C), 72.1 (CH2), 69.9 (Ins C), 69.6 (Ins C), 68.1 (Ins C),
67.4 (Ins C), 64.2 ppm (Ins C); IR (CHCl3): n˜ =1722 cmÀ1; elemental
analysis calcd (%) for C28H24O8: C 68.84, H 4.95; found: C 68.57, H 4.61.
Solid-state transesterification reaction of form II crystals of rac-3:
Form II crystals of rac-3 (0.032 g, 0.08 mmol) and anhydrous sodium car-
bonate (0.07 g, 0.7 mmol) were mixed together and ground to a fine
powder by using a pestle and mortar. This mixture was heated in a glass
stoppered test tube at 1158C under an argon atmosphere for 195 h. The
reaction mixture was cooled to room temperature and the products were
extracted with chloroform/methanol 1:1 (2ꢂ10 mL). The mixture of
d-4-O-Benzyl-myo-inositol (ent-14): Compound ent-12 (0.021 g,
0.08 mmol) was treated with trifluoroacetic acid and water (0.4+0.1 mL)
at room temperature for 24 h (as in the preparation of 14) to give ent-14
as white needle-type crystals (0.017 g, 84%). M.p. 175–1768C (lit.:[29a]
products obtained on evaporation of the solvent was separated by preACHTUNGTRENNUNGpar-
AHCTUNGTREGaNNUN tive TLC to give the tribenzoate 6 (0.017 g, 42%; m.p. 153–1558C
(lit.:[36] m.p. 154–1558C)) and the diol 9 (0.01 g, 42%; m.p. 158–1598C
(lit.:[37] m.p. 1608C)) as white solids.
Chem. Eur. J. 2009, 15, 261 – 269
ꢀ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
267